Insider Transactions in Q3 2025 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+19.11%
|
$250,670
$2.43 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-10.06%
|
$2,376,700
$50.53 P/Share
|
|
Jul 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,792
-2.94%
|
$139,600
$50.58 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-17.64%
|
$544,307
$47.7 P/Share
|
|
Jul 14
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,587
+10.36%
|
$37,935
$5.01 P/Share
|
|
Jul 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,572
-1.6%
|
$120,884
$47.82 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-16.63%
|
$532,726
$46.67 P/Share
|
|
Jul 07
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+8.46%
|
$32,185
$5.01 P/Share
|